Company news

Vicore Pharma Holding AB news in 2025

Vicore Pharma Holding AB's news releases, calls and decks from 2025, newest first.

View company

Vicore Pharma To Move To The Nasdaq Stockholm Mid Cap Segment

December 19, 2025

Vicore to Present at the Oppenheimer Movers in Rare Disease Summit

December 5, 2025

Increase in Number of Shares and Votes in Vicore Pharma

November 28, 2025

Vicore to Present at the DNB Carnegie Nordic Healthcare Conference

November 20, 2025

Vicore to Present at The Jefferies Global Healthcare Conference in London

November 17, 2025

Vicore Pharma announces successful execution of a directed share issue of approximately USD 48 million (approximately SEK 455 million)

November 12, 2025

Vicore to Present at Upcoming Investor Conferences

November 5, 2025

Interim Report July - September 2025

November 5, 2025

Vicore Announces The Nomination Committee For The 2026 Annual General Meeting

November 3, 2025

Buloxibutid Receives Orphan Drug Designation in Japan for the Treatment of Idiopathic Pulmonary Fibrosis

September 30, 2025

Vicore Announces Presentations at the European Respiratory Society Congress 2025

September 23, 2025

Vicore to Present at Pareto Securities' 16th Annual Healthcare Conference

September 15, 2025

Interim Report April - June 2025

August 22, 2025

Vicore to Present at the Jefferies Global Healthcare Conference

May 28, 2025

Vicore Presents New Data at the 2025 American Thoracic Society International Conference

May 22, 2025

Interim Report January – March 2025

May 6, 2025

Vicore to Present at the Nordea Equities Healthcare Seminar

May 2, 2025

Vicore Announces Presentations at the 2025 American Thoracic Society International Conference

April 23, 2025

Decks in 2025